{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12828463", "DateCompleted": {"Year": "2003", "Month": "11", "Day": "20"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "66", "Issue": "6", "PubDate": {"Year": "2003", "Month": "Jun"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats.", "Pagination": {"StartPage": "788", "EndPage": "792", "MedlinePgn": "788-92"}, "Abstract": {"AbstractText": ["The antihyperglycemic action of puerarin, purified from the roots of Pueraria lobata, was investigated in streptozotocin-induced diabetic rats (STZ-diabetic rats). Bolus intravenous injection of puerarin decreased the plasma glucose concentrations in a dose-dependent manner in STZ-diabetic rats. Similar treatment with puerarin also decreased the plasma glucose in normal rats, although the effect was not as great as that in STZ-diabetic rats. Puerarin at the effective dose (15.0 mg/kg) significantly attenuated the increase of plasma glucose induced by an intravenous glucose challenge test in normal rats. In the isolated soleus muscle of STZ-diabetic rats, puerarin enhanced the uptake of radioactive glucose in a concentration-dependent manner. Moreover, the mRNA and protein levels of the subtype 4 form of glucose transporter (GLUT4) in soleus muscle were increased after repeated intravenous administration of puerarin in STZ-diabetic rats for 3 days. These results suggest that puerarin can increase the glucose utilization to lower plasma glucose in diabetic rats lacking insulin."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacognosy, School of Pharmacy, Taipei Medical University, Taipei City, Taiwan 110-31."}], "Identifier": [], "LastName": "Hsu", "ForeName": "Feng-Lin", "Initials": "FL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "I-Min", "Initials": "IM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kuo", "ForeName": "Daih-Huang", "Initials": "DH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chen", "ForeName": "Wang-Chuan", "Initials": "WC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Su", "ForeName": "Hui-Chen", "Initials": "HC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cheng", "ForeName": "Juei-Tang", "Initials": "JT"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucose Transporter Type 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Monosaccharide Transport Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Muscle Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Slc2a4 protein, rat"}, {"RegistryNumber": "5W494URQ81", "NameOfSubstance": "Streptozocin"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}, {"RegistryNumber": "Z9W8997416", "NameOfSubstance": "puerarin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["blood", "drug therapy"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose"}, {"QualifierName": [], "DescriptorName": "Glucose Transporter Type 4"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Isoflavones"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Monosaccharide Transport Proteins"}, {"QualifierName": [], "DescriptorName": "Muscle Proteins"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Muscle, Skeletal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Roots"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Pueraria"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Streptozocin"}, {"QualifierName": [], "DescriptorName": "Taiwan"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "6", "Day": "28", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "12", "Day": "3", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "6", "Day": "28", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12828463", "10.1021/np0203887"]}}], "PubmedBookArticle": []}